LONDON, April 30, 2010 /PRNewswire/ -- Chiltern International Limited (Chiltern), a global clinical contract research organization (CRO) announced that Chiltern has won an award at the inaugural PharmaTimes US Clinical Researcher of the Year Awards 2010 ceremony held at the Sheraton Hotel in Philadelphia last night. The competition, established in Europe in 1999, celebrates the competence and ability of top clinical research professionals. Chiltern has won in several categories in the PharmaTimes European Clinical Researcher of the Year competition over the years.

Glenn Kerkhof, Chiltern CEO, congratulated Kim Todd, Chiltern's Silver Medal Award Winner in the category of experienced Clinical Research Associate/Site Manager of the Year. I am very proud of Kim. She puts her best forward each and every day for our clients and her dedication to being the best is evident in all she does. This achievement is a direct result of Chiltern's commitment to deliver expert, high quality services around the world.

Kim Todd has 24 years combined experience in healthcare and clinical research. Her therapeutic areas of experience include chronic obstructive pulmonary disease, allergy, asthma, psychiatry, cardiovascular/hyponatremia, osteoarthritis, immunology, pediatrics and ophthalmology.

Stuart Young, Chiltern Executive VP, Clinical Monitoring, stated, Making it through the rigorous stages of the PharmaTimes application process is no small feat and I am delighted that Kim has received the recognition that is so well-deserved. She is a shining example of the Chiltern team.

Company profile

About Chiltern:

Established in 1982, Chiltern is a leading global Contract Research Organization with extensive experience conducting and staffing international Phase I to Phase IV clinical trials across a broad range of therapeutic areas for a wide variety of clients. Chiltern has conducted trials in more than 40 countries, has 24 offices and legal entities within 20 countries, resources in 37 countries and employs nearly 1,400 people globally. Chiltern provides Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions services. Further information: http://www.chiltern.com.

Contact: Natalie Chong Susan Ojanen Chiltern International Ltd. Chiltern International Inc. 171 Bath Road 1241 Volunteer Parkway Slough Suite 950 Berkshire SL1 4AA Bristol, TN 37620 UNITED KINGDOM USA Tel: +44-(0)-1753-512-000 Tel: +1-(423)-968-9533 Email: natalie.chong@chiltern.com Email: susan.ojanen@chiltern.com

SOURCE: Chiltern International Limited

CONTACT: Natalie Chong, +44-(0)-1753-512 000, natalie.chong@chiltern.com,or Susan Ojanen, +1-423-968-9533, susan.ojanen@chiltern.com, both ofChiltern